A strong trend towards an interaction was seen when comparing patients with 24–<36 months' persistence and patients with ≥36 months' persistence (HR: 1.04; 95% CI: 1.00–1.08; P = 0.0579; Table 3 ).
← all excerpts
The impact of persistence with bisphosphonates on health resource utilization and fracture risk in the UK: a study of patient records from the UK Clinical Practice Research Datalink.
1
—
—